Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3026% below fair value
$80.39+1.28 (+1.62%)
Close on Nov 13, 2026Market cap $1.98BP/E –Yield 2.13%
Innospec EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was $4.67, up 228.9% from the year before. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $5.56 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.67 | +228.9% |
| FY2024 | Dec 31, 2024 | $1.42 | -74.5% |
| FY2023 | Dec 31, 2023 | $5.56 | +4.5% |
| FY2022 | Dec 31, 2022 | $5.32 | +41.9% |
| FY2021 | Dec 31, 2021 | $3.75 | +223.3% |
| FY2020 | Dec 31, 2020 | $1.16 | -74.4% |
| FY2019 | Dec 31, 2019 | $4.54 | +31.6% |
| FY2018 | Dec 31, 2018 | $3.45 | +36.9% |
| FY2017 | Dec 31, 2017 | $2.52 | -24.3% |
| FY2016 | Dec 31, 2016 | $3.33 | -31.5% |
| FY2015 | Dec 31, 2015 | $4.86 | +43.8% |
| FY2014 | Dec 31, 2014 | $3.38 | +5.0% |
| FY2013 | Dec 31, 2013 | $3.22 | +14.6% |
| FY2012 | Dec 31, 2012 | $2.81 | +46.4% |
| FY2011 | Dec 31, 2011 | $1.92 | -35.4% |
| FY2010 | Dec 31, 2010 | $2.97 | +1042.3% |
| FY2009 | Dec 31, 2009 | $0.26 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.29 | +37.2% |
| Q2 FY2026 | Jun 30, 2026 | $1.25 | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.22 | -8.3% |
| Q3 FY2025 | Sep 30, 2025 | $0.52 | -58.1% |
| Q2 FY2025 | Jun 30, 2025 | $0.94 | -43.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.31 | -16.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.33 | +14.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.24 | -6.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.65 | +6.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.57 | +21.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.16 | -20.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.33 | +41.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.55 | +72.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.29 | +37.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.46 | +186.3% |
| Q3 FY2021 | Sep 30, 2021 | $0.94 | – |
| Q2 FY2021 | Jun 30, 2021 | $0.90 | -32.8% |
| Q1 FY2021 | Mar 31, 2021 | $0.94 | -23.0% |
| Q3 FY2020 | Sep 30, 2020 | $0.51 | -43.3% |
| Q2 FY2020 | Jun 30, 2020 | -$1.62 | -238.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.34 | +59.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.22 | +37.1% |
| Q2 FY2019 | Jun 30, 2019 | $0.90 | 0.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.17 | +23.2% |
| Q3 FY2018 | Sep 30, 2018 | $0.84 | -20.8% |
| Q2 FY2018 | Jun 30, 2018 | $0.89 | +27.1% |
| Q1 FY2018 | Mar 31, 2018 | $0.90 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.95 | – |
| Q2 FY2017 | Jun 30, 2017 | $1.06 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.70 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?